The risk of contralateral breast cancer in daughters of women with and without breast cancer

被引:15
作者
Narod, S. A. [1 ]
Kharazmi, E. [2 ]
Fallah, M. [2 ]
Sundquist, K. [3 ,4 ]
Hemminki, K. [2 ,3 ]
机构
[1] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada
[2] German Canc Res Ctr, Div Mol Genet Epidemiol, Neuenheimer Feld 580, D-69120 Heidelberg, Germany
[3] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[4] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
关键词
contralateral breast cancer; familial cancer; hereditary cancer; risk assessment; BRCA2 MUTATION CARRIERS; EPIDEMIOLOGY;
D O I
10.1111/cge.12604
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We aimed to estimate the 15-year and lifetime risks of contralateral breast cancer in breast cancer patients according to the age of diagnosis of the first cancer and the history of breast cancer in the mother. The risks of contralateral breast cancer were estimated for all 78,775 breast cancer patients in the Swedish Family-Cancer Database (age at diagnosis of first breast cancer <70 years). The risk of experiencing a contralateral breast cancer within 15 years of diagnosis was 8.4% [95% confidence interval (CI): 8.1-8.7%] for women with an unaffected mother, was 12% (95%CI: 11-13%) for a woman with a mother with unilateral breast cancer and was 13% (95%CI: 9.5-17%) for women with a mother with bilateral breast cancer. In early-onset diagnosed women (<50 years) with an unaffected mother, the risk of contralateral breast cancer until age 80 was 23% (95%CI: 20-26%) and for late-onset (50-69 years) diagnosed women it was 17% (95%CI: 14-21%). In a woman with a mother with an early-onset unilateral breast cancer, risk of contralateral breast cancer by age 80 was 35% (95%CI: 25-46%). Women with a mother with early-onset bilateral breast cancer had 31% (95%CI: 12-67%) lifetime risk of contralateral breast cancer. The risk of contralateral breast cancer is higher for daughters of breast cancer patients than for daughters of women without breast cancer. Maternal cancer history and age at onset of first breast cancer in women should be taken into account when counseling breast cancer patients about their risk of contralateral breast cancer.
引用
收藏
页码:332 / 335
页数:4
相关论文
共 8 条
[1]   THE GENETIC EPIDEMIOLOGY OF 2ND PRIMARY BREAST-CANCER [J].
BERNSTEIN, JL ;
THOMPSON, WD ;
RISCH, N ;
HOLFORD, TR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (08) :937-948
[2]  
Hemminki K, 2001, ACTA ONCOL, V40, P772
[3]   Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes:: a familial study [J].
Johnson, N ;
Fletcher, O ;
Naceur-Lombardelli, C ;
Silva, ID ;
Ashworth, A ;
Peto, J .
LANCET, 2005, 366 (9496) :1554-1557
[4]   Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers [J].
Metcalfe, K ;
Lynch, HT ;
Chadirian, P ;
Tung, N ;
Olivotto, V ;
Warner, E ;
Olopade, OI ;
Eisen, A ;
Weber, B ;
McLennan, J ;
Sun, P ;
Foulkes, WD ;
Narod, SA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2328-2335
[5]   Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers [J].
Metcalfe, K. ;
Gershman, S. ;
Lynch, H. T. ;
Ghadirian, P. ;
Tung, N. ;
Kim-Sing, C. ;
Olopade, O. I. ;
Domchek, S. ;
McLennan, J. ;
Eisen, A. ;
Foulkes, W. D. ;
Rosen, B. ;
Sun, P. ;
Narod, S. A. .
BRITISH JOURNAL OF CANCER, 2011, 104 (09) :1384-1392
[6]   Bilateral breast cancers [J].
Narod, Steven A. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (03) :157-166
[7]   Risk of Asynchronous Contralateral Breast Cancer in Noncarriers of BRCA1 and BRCA2 Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study [J].
Reiner, Anne S. ;
John, Esther M. ;
Brooks, Jennifer D. ;
Lynch, Charles F. ;
Bernstein, Leslie ;
Mellemkjaer, Lene ;
Malone, Kathleen E. ;
Knight, Julia A. ;
Capanu, Marinela ;
Teraoka, Sharon N. ;
Concannon, Patrick ;
Liang, Xiaolin ;
Figueiredo, Jane C. ;
Smith, Susan A. ;
Stovall, Marilyn ;
Pike, Malcolm C. ;
Haile, Robert W. ;
Thomas, Duncan C. ;
Begg, Colin B. ;
Bernstein, Jonine L. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) :433-439
[8]  
Stegmayr B, 2007, CANC INCIDENCE SWEDE, P30